GT Biopharma
GTBP0.31712.76% ( -0.0090 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: GT Biopharma(GTBP) predict that the Revenue is 0 (--%), Meet estimate;the EBIT is -2.848 M (-47.41%), Miss estimate;the EPS is -0.11 (+66.67%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B--
0.00B--
0.00B--%
EBITMiss expectations
-0.00B47.41%
-0.00B30.07%
-0.00B17.34%
EPSMiss expectations
-0.1166.67%
-0.0875.76%
-0.03009.09%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf